Sun Pharmaceutical Industries Limited (BOM:524715)

Market Cap	4.30T +11.1%
Revenue (ttm)	568.09B +10.1%
Net Income	109.15B -4.5%
EPS	45.45 -4.7%
Shares Out	n/a
PE Ratio	39.43
Forward PE	32.55
Dividend	16.50 (0.92%)
Ex-Dividend Date	Feb 5, 2026

Volume	75,404
Average Volume	119,731
Open	1,799.05
Previous Close	1,794.85
Day's Range	1,785.40 - 1,819.15
52-Week Range	1,547.25 - 1,850.95
Beta	n/a
RSI	56.80
Earnings Date	May 22, 2026

About BOM:524715

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, urology, dermatology, respira...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 43,000
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524715

Financial Performance

In fiscal year 2025, BOM:524715's revenue was 525.78 billion, an increase of 8.42% compared to the previous year's 484.97 billion. Earnings were 109.29 billion, an increase of 14.12%.